Methods In October 2021, primary care clinics enrolled consenting 18-to 89-year-olds to
complete an online questionnaire on self-diagnosis, clinician diagnosis, testing, symptom …

Background Coronavirus disease 2019 (COVID-19) may cause myocardial injury and
myocarditis, and reports of persistent cardiac pathology after COVID-19 have raised …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) or coronavirus disease
2019 (COVID-19) initially surfaced in December 2019 from Wuhan, China, sweeping the …

Background COVID‐19 has a wide spectrum of cardiovascular sequelae including
myocarditis and pericarditis; however, the prevalence and clinical impact are unclear. We …

Background The incidence of persistent clinical symptoms and risk factors in Post-Acute
Sequelae of SARS-CoV-2 (PASC) in diverse US cohorts is unclear. While there are a …

Autoimmune responses mediated by autoantibodies have been observed in SARS-CoV-2
infection. Herein, we evaluate the presence of rheumatic, thyroid and phospholipid …

The aim of this study is to evaluate the blood level of anti‐heart antibodies (AHA) and its
correlation with clinical outcomes in patients with severe and moderate coronavirus disease …

Emerging evidence suggests that COVID-19 may affect cardiac autonomic function;
however, the limited findings in young adults with COVID-19 have been equivocal. Notably …

Background The complications and sequelae of coronavirus disease 2019 (COVID-19) and
their effect on long-term health are unclear, and the trajectory of associated immune …

With the emerging success of the COVID-19 vaccination programs, the incidence of acute
COVID-19 will decrease. However, given the high number of people who contracted SARS …